Envoy Medical (COCH) grants director Chas McKhann 100,000 options

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Envoy Medical, Inc. director Chas McKhann received a grant of stock options covering 100,000 shares of Class A common stock. The options have an exercise price of $0.72 per share and expire on April 15, 2036.

Beginning May 15, 2026, these options vest pro rata on the 15th of each month over 36 consecutive months. After this grant, McKhann holds stock options for 100,000 underlying shares directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider McKhann Chas

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	100,000	$0.00	--

Holdings After Transaction: Stock Option (Right to Buy) — 100,000 shares (Direct)

Footnotes (1)

[object Object]

Key Figures

Option grant size: 100,000 options Exercise price: $0.72 per share Underlying shares: 100,000 shares +2 more

5 metrics

Option grant size 100,000 options Stock Option (Right to Buy) granted to director

Exercise price $0.72 per share Conversion or exercise price of stock options

Underlying shares 100,000 shares Class A Common Stock underlying the options

Expiration date April 15, 2036 Option expiration for the granted stock options

Vesting schedule length 36 months Monthly pro rata vesting starting May 15, 2026

Key Terms

Stock Option (Right to Buy), Class A Common Stock, exercise price, vest pro rata, +1 more

5 terms

Stock Option (Right to Buy) financial

"security_title: Stock Option (Right to Buy)"

Class A Common Stock financial

"underlying_security_title: Class A Common Stock"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

exercise price financial

"conversion_or_exercise_price: 0.7200"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vest pro rata financial

"options to purchase Class A Common Stock will vest pro rata"

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

04/17/2026 - 04:32 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McKhann Chas

(Last)

(First)

(Middle)

4875 WHITE BEAR PARKWAY

(Street)

WHITE BEAR LAKE

MINNESOTA

55110

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Envoy Medical, Inc. [ COCH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)	$0.72	04/15/2026		A		100,000		⁽¹⁾	04/15/2036	Class A Common Stock	100,000	$0	100,000	D

Explanation of Responses:

1. Beginning on 5/15/2026, options to purchase Class A Common Stock will vest pro rata on the 15th of each month for 36 consecutive months.

	/s/ Andrew Nick as Attorney-in-Fact for Chas McKhann pursuant to Power of Attorney previously filed.	04/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Envoy Medical (COCH) report for Chas McKhann?

Envoy Medical reported that director Chas McKhann received a grant of stock options for 100,000 shares of Class A common stock. These options are a compensation-related award rather than an open-market purchase or sale of existing shares.

What are the key terms of Chas McKhann’s stock options at Envoy Medical (COCH)?

The grant covers 100,000 underlying shares with an exercise price of $0.72 per share and an expiration date of April 15, 2036. These options give McKhann the right to buy Envoy Medical Class A common stock at that fixed price.

How do Chas McKhann’s Envoy Medical (COCH) stock options vest over time?

Vesting begins on May 15, 2026, with options vesting pro rata on the 15th of each month for 36 consecutive months. This schedule gradually makes portions of the 100,000-share grant exercisable over a three-year period.

Did Chas McKhann buy or sell Envoy Medical (COCH) shares in this Form 4?

The Form 4 shows an acquisition through a stock option grant, coded as an award, not an open-market trade. McKhann received 100,000 options as compensation, and no purchases or sales of existing common shares are reported in this filing.

How many Envoy Medical (COCH) options does Chas McKhann hold after this grant?

After this transaction, McKhann holds stock options covering 100,000 shares of Envoy Medical Class A common stock directly. This figure reflects the total derivative position reported in the filing following the new option award.